NEUROCRINE BIOSCIENCES
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 193 M
Avg. Deal Size£ 96 M
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Kevin Gorman
Co-Founder and CEO
Kyle Gano
Chief Business Development and Strategy Officer
Jude Onyia
Chief Scientific Officer
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy